Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
Two pivotal Phase 3 clinical trials studying soticlestat as a treatment for Lennox-Gastaut syndrome (LGS) and Dravet syndrome (DS) completed […]
Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update
FARMINGTON HILLS, Mich., March 08, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on […]
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
GARDEN CITY, NY, March 08, 2024 (GLOBE NEWSWIRE) — ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be […]
Treasure Global’s AI-Powered ZCITY Premium Store Surpasses Expectations, Selling over 6,000 Bill Saver Bonanza Packs Within Four Months of Launch
NEW YORK and KUALA LUMPUR, Malaysia, March 08, 2024 (GLOBE NEWSWIRE) — Treasure Global Inc (NASDAQ: TGL) (“TGL,” “Treasure Global” […]
BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute
GAITHERSBURG, Md., March 08, 2024 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), […]
Silver Spike Investment Corp. Declares Cash Dividend for First Quarter 2024
NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) — Silver Spike Investment Corp. (“Silver Spike” or the “Company”) (NASDAQ: SSIC), a […]
Olink announces change of date for Annual General Meeting
UPPSALA, Sweden, March 08, 2024 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that Olink’s 2024 […]
Cavco Industries Receives Training Magazine APEX Award Recognition
PHOENIX, March 08, 2024 (GLOBE NEWSWIRE) — Cavco Industries, Inc. (Nasdaq: CVCO) is proud to announce that it was recognized […]
Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients
Only Daxor’s BVA Diagnostic Was Shown to Accurately Reflect Blood Volume Compared to Inferior Surrogates Oak Ridge, TN, March 08, […]
SELLAS Announces Executive Leadership Reorganization and Prioritization of Commercialization Partnerships
NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a […]
